Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency Chemical Research in Toxicology They Call It the 'Wolverine Peptide.' And Everyone from Biohackers to Your Dad Wants It Now. Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or